Inventor · disambiguated record
Anil Vasudevan
Also filed as: VASUDEVAN ANIL
38 granted patents·26 pending applications·273 citations·filing 2001–2021
97Inventor score
Top patents by PatentIndex Score
64 records- 0192US8648069B25-substituted indazoles as kinase inhibitorsAKRITOPOULOU-ZANZE IRINI·Filed 2008·Granted Feb 11, 2014·44 cites·7 claims
- 0292US6989392B22-Aminoquinolines as melanin concentrating hormone receptor antagonistsABBOTT LAB·Filed 2003·Granted Jan 24, 2006·39 cites·14 claims
- 0390US7491718B2Sulfonamides having antiangiogenic and anticancer activityABBOTT LAB·Filed 2003·Granted Feb 17, 2009·35 cites·3 claims
- 0489US10233179B2Thiazoles and uses thereofABBVIE INC·Filed 2014·Granted Mar 19, 2019·31 cites·37 claims
- 0588US6559140B2Cyclic and bicyclic diamino histamine-3 receptor antagonistsABBOTT LAB·Filed 2001·Granted May 6, 2003·24 cites·21 claims
- 0685US7998993B2TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·8 cites·15 claims
- 0784US10556914B2Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of useABBVIE INC·Filed 2019·Granted Feb 11, 2020·4 cites·16 claims
- 0884US9163007B25-substituted indazoles as kinase inhibitorsABBVIE INC·Filed 2013·Granted Oct 20, 2015·8 cites·6 claims
- 0982US6818772B2Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptorABBOTT LAB·Filed 2003·Granted Nov 16, 2004·17 cites·35 claims
- 1081US7998982B2Amide derivatives as TRPV1 antagonistsABBOTT LAB·Filed 2008·Granted Aug 16, 2011·4 cites·6 claims
- 1181US7956185B2Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinasesABBOTT LAB·Filed 2007·Granted Jun 7, 2011·5 cites·5 claims
- 1281US6515013B21,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applicationsABBOTT LAB·Filed 2001·Granted Feb 4, 2003·12 cites·15 claims
- 1379US9656955B2Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted May 23, 2017·2 cites·20 claims
- 1478US9856253B2Tricyclic modulators of TNF signalingABBVIE INC·Filed 2016·Granted Jan 2, 2018·2 cites·19 claims
- 1577US8445686B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsMACK HELMUT·Filed 2008·Granted May 21, 2013·3 cites·21 claims
- 1675US9879016B2Indazolones as modulators of TNF signalingABBVIE INC·Filed 2016·Granted Jan 30, 2018·2 cites·26 claims
- 1775US8895749B24-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 25, 2014·2 cites·11 claims
- 1874US9108905B2TRPA1 antagonistsPERNER RICHARD J·Filed 2009·Granted Aug 18, 2015·3 cites·4 claims
- 1974US6620839B21,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applicationsABBOTT LAB·Filed 2002·Granted Sep 16, 2003·11 cites·19 claims
- 2073US9302989B2NAMPT and rock inhibitorsCURTIN MICHAEL L·Filed 2011·Granted Apr 5, 2016·4 cites·20 claims
- 2173US8877784B2TRPA1 antagonistsPERNER RICHARD J·Filed 2009·Granted Nov 4, 2014·2 cites·4 claims
- 2271US8551981B2Furo[3,2-d]pyrimidine compoundsCALDERWOOD DAVID J·Filed 2011·Granted Oct 8, 2013·3 cites·29 claims
- 2371US6921821B2Antagonists of melanin concentrating hormone receptorABBOTT LAB·Filed 2003·Granted Jul 26, 2005·7 cites·23 claims
- 2469US2021179556A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2021·Application pending·0 cites
- 2567US8859546B2Picolinamide inhibitors of kinasesVASUDEVAN ANIL·Filed 2012·Granted Oct 14, 2014·1 cites·15 claims
- 2666US2019284135A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2019·Application pending·0 cites
- 2765US9567339B2Primary carboxamides as BTK inhibitorsABBVIE INC·Filed 2014·Granted Feb 14, 2017·0 cites·20 claims
- 2859US9586945B2Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 7, 2017·0 cites·21 claims
- 2959US9586942B2Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted Mar 7, 2017·0 cites·20 claims
- 3058US9751850B2TRPA1 antagonistsABBVIE INC·Filed 2014·Granted Sep 5, 2017·0 cites·4 claims
- 3158US2015105386A14-(4-pyridinyl)-benzamides and their use as rock activity modulatorsABBVIE DEUTSCHLAND·Filed 2014·Application pending·0 cites
- 3258US2019290632A1Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 3358US2019290645A1Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 3458US2017174624A1Primary carboxamides as btk inhibitorsABBVIE INC·Filed 2017·Application pending·0 cites
- 3554US10266532B2Tricyclic modulators of TNF signalingABBVIE INC·Filed 2017·Granted Apr 23, 2019·0 cites·18 claims
- 3653US2009258907A1Compounds useful as inhibitors of rock kinasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 3752US2017172993A1Aminotetraline and aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 3852US2010035919A1Compounds useful as inhibitors of protein kinasesABBOTT LAB·Filed 2009·Application pending·0 cites
- 3952US2017173009A1Aminochromane, aminothiochromane and amino-1,2,3,4-tetrahydroquinoline derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 4050US2014155389A1Bicyclic inhibitors of alkVASUDEVAN ANIL·Filed 2012·Application pending·0 cites
- 4150US2014171429A1Bicyclic inhibitors of alkVASUDEVAN ANIL·Filed 2012·Application pending·0 cites
- 4249US10273238B2Indazolones as modulators of TNF signalingABBVIE INC·Filed 2017·Granted Apr 30, 2019·0 cites·22 claims
- 4349US2006030557A1Substituted pyridines having antiangiogenic activityHAVIV FORTUNA·Filed 2005·Application pending·0 cites
- 4448US2004014744A1Substituted pyridines having antiangiogenic activityFiled 2003·Application pending·0 cites
- 4546US9650334B2Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2014·Granted May 16, 2017·0 cites·20 claims
- 4646US2011288129A1Amide derivatives as trpv1 antagonistsVASUDEVAN ANIL·Filed 2011·Application pending·0 cites
- 4745US2017073353A1Substituted isoxazolopyridazinones and isothiazolopyridazinones and methods of useABBVIE INC·Filed 2016·Application pending·0 cites
- 4843US9957274B2Indane inhibitors of EED and methods of their useABBVIE INC·Filed 2017·Granted May 1, 2018·0 cites·9 claims
- 4942US2005137243A1Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptorFiled 2003·Application pending·0 cites
- 5041US9550754B24,5-dihydropyrazole derivatives, pharmaceutical compositions containing them, and their use in therapyABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 24, 2017·0 cites·20 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anil Vasudevan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →